BOSTON, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics ...
REDWOOD CITY, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- The Procurement Compass, a leading online platform for procurement insights and strategies, advances in the industry under the leadership ...